Spring Bank Ph CS (SBPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SBPH | AMGN | VRTX | GILD | BMY |
| Company | Spring Bank Ph CS | Amgen Inc | Vertex Pharmaceutic | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 5.2192 | 277.00 | 461.35 | 91.60 | 58.30 |
| High | 5.2192 | 279.04 | 467.06 | 94.27 | 59.11 |
| Low | 4.6000 | 274.30 | 458.37 | 91.60 | 58.23 |
| Last | 4.8400 | 275.15 | 459.39 | 93.13 | 58.96 |
| Change | unch | -3.11 | -4.59 | +1.54 | +0.59 |
| % Change | unch | -1.12% | -0.99% | +1.68% | +1.01% |
| Volume | 21,675 | 1,179,693 | 456,758 | 5,490,655 | 3,513,344 |
| 20-Day Average Volume | 66,920 | 4,504,572 | 1,333,368 | 7,463,233 | 11,104,211 |
| Previous Close | 4.8400 | 278.26 | 463.98 | 91.59 | 58.37 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.2170 | 291.32 | 471.55 | 92.09 | 58.13 |
| 20-Day Raw Stochastic | 42.00% | 24.34% | 20.09% | 54.80% | 68.71% |
| 20-Day Relative Strength | 45.55% | 32.39% | 45.60% | 58.61% | 59.43% |
| Weighted Alpha | -22.20 | -6.15 | +21.72 | +27.65 | +26.25 |
| Today's Opinion | 80% Sell | 72% Sell | 24% Sell | 100% Buy | 100% Buy |
| Previous Opinion | 80% Sell | 72% Sell | 8% Sell | 88% Buy | 100% Buy |
| Last Month's Opinion | 88% Sell | 8% Buy | 88% Buy | 100% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -9.02% since 11/13/20 | -1.83% since 11/27/24 | -0.97% since 11/27/24 | +0.75% since 11/27/24 | -0.70% since 11/27/24 |
| Low | 1.1500 on 11/20/20 | 273.86 on 12/04/24 | 450.00 on 12/04/24 | 89.86 on 12/04/24 | 57.59 on 12/04/24 |
| High | 1.4000 on 11/16/20 | 283.64 on 11/29/24 | 470.93 on 11/29/24 | 94.39 on 12/03/24 | 60.09 on 12/03/24 |
| 1-Month | |||||
| %Chg | -3.20% since 10/20/20 | -13.89% since 11/05/24 | -7.97% since 11/05/24 | +3.20% since 11/05/24 | +5.19% since 11/05/24 |
| Low | 0.9710 on 10/30/20 | 257.80 on 11/26/24 | 445.00 on 11/21/24 | 86.08 on 11/19/24 | 53.97 on 11/08/24 |
| High | 1.5400 on 11/12/20 | 328.25 on 11/08/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 | 61.08 on 11/11/24 |
| 3-Month | |||||
| %Chg | -14.79% since 08/20/20 | -15.23% since 09/05/24 | -1.82% since 09/05/24 | +18.20% since 09/05/24 | +18.18% since 09/05/24 |
| Low | 0.9710 on 10/30/20 | 257.80 on 11/26/24 | 445.00 on 11/21/24 | 78.26 on 09/06/24 | 47.55 on 09/09/24 |
| High | 1.5500 on 09/03/20 | 339.17 on 09/23/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 | 61.08 on 11/11/24 |
| 6-Month | |||||
| %Chg | -26.67% since 05/20/20 | -10.55% since 06/05/24 | -4.76% since 06/05/24 | +45.75% since 06/05/24 | +42.71% since 06/05/24 |
| Low | 0.9710 on 10/30/20 | 257.80 on 11/26/24 | 445.00 on 11/21/24 | 62.69 on 06/18/24 | 39.35 on 07/05/24 |
| High | 2.7900 on 07/28/20 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 | 61.08 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 20,893 | 149,573,936 | 119,488,304 | 114,145,504 | 118,384,688 |
| Shares Outstanding, K | 17,267 | 537,533 | 257,529 | 1,246,266 | 2,028,177 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 27,116,000,000 | 45,006,000,000 |
| Annual Net Income | -24,100,000 | 6,717,000,000 | 3,619,600,000 | 5,665,000,000 | 8,025,000,000 |
| Last Quarter Sales | 0 | 8,503,000,000 | 2,771,900,000 | 7,545,000,000 | 11,892,000,000 |
| Last Quarter Net Income | -5,360,000 | 2,830,000,000 | 1,045,400,000 | 1,253,000,000 | 1,211,000,000 |
| 60-Month Beta | 1.13 | 0.55 | 0.36 | 0.18 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 | 1.80 on 10/31/24 |
| Latest Earnings Date | 11/26/20 | 10/30/24 | 11/04/24 | 11/06/24 | 10/31/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | N/A | 0.770 on 09/13/24 | 0.600 on 10/04/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | N/A | 12/13/24 | 10/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.48 | 0.00 | 20.88 | 50.16 |